REDIC: Refractive Disorders and Seric Vitamin D Level in Children With Disabilities

Sponsor
Holhos Larisa Bianca (Other)
Overall Status
Completed
CT.gov ID
NCT04827511
Collaborator
(none)
161
1
26.9
6

Study Details

Study Description

Brief Summary

The investigator want to determine the refractive status of 80 children with disabilities and of 81 healthy children from a witness group. The vitamin D level of the children will be dosed for making different correlations with visual acuity status.

Condition or Disease Intervention/Treatment Phase
  • Other: Refraction measurement with auto-ref-keratometer Canon

Detailed Description

Refraction measurement will be done by the investigator in all 161 children. Visual acuity is checked, initial and after correction with proper correction. Vitamin D level is dosed from all the children in order to make correlations with the visual acuity, refractive status and risk for visual impairment.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
161 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Refractive Disorders and Seric Vitamin D Level in Children With Disabilities
Actual Study Start Date :
Jan 1, 2019
Actual Primary Completion Date :
Aug 31, 2020
Actual Study Completion Date :
Mar 31, 2021

Arms and Interventions

Arm Intervention/Treatment
cohort group

80 children with disabilities like autism, ADHD, Down syndrome, deafness, phocomelia, dyslexia, different motor problems

Other: Refraction measurement with auto-ref-keratometer Canon
Refractive measurement and vitamin D level dosing

control group

81 healthy children, not known or diagnosed with a chronic disease of any kind

Other: Refraction measurement with auto-ref-keratometer Canon
Refractive measurement and vitamin D level dosing

Outcome Measures

Primary Outcome Measures

  1. Refractive disorders in children with disabilities [1 January 2019-31 August 2020]

    Prevalence of refractive disorders in children with disabilities

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • children with disabilities and healthy children
Exclusion Criteria:
  • children diagnosed with another chronic diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 HolhoÈ™ Larisa Bianca Marghita Bihor Romania 415300

Sponsors and Collaborators

  • Holhos Larisa Bianca

Investigators

  • Principal Investigator: HolhoÈ™ L Bianca, Doctor, Faculty of Medicine and Pharmacy Oradea

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Holhos Larisa Bianca, Specialist in Ophthalmology, Elisantes Teola SRL
ClinicalTrials.gov Identifier:
NCT04827511
Other Study ID Numbers:
  • 142312202069
First Posted:
Apr 1, 2021
Last Update Posted:
Apr 5, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Holhos Larisa Bianca, Specialist in Ophthalmology, Elisantes Teola SRL
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 5, 2021